Correspondence 0001178913-24-003147 from Evogene Ltd. (EVGN)
Evogene Ltd.
Date: Sept. 25, 2024 · CIK: 0001574565 · Accession: 0001178913-24-003147
AI Filing Summary & Sentiment
File numbers found in text: 333-282218
Show Raw Text
CORRESP
1
filename1.htm
Evogene Ltd.
13 Gad Feinstein Street, Park Rehovot
Rehovot 7638517, Israel
September 25, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attention: Conlon Danberg
Re:
Evogene Ltd.
Registration Statement on Form F-1
Filed September 19, 2024
File No. 333-282218
Dear Mr. Danberg:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Evogene Ltd. hereby requests that the effective date of the above-referenced Registration Statement on Form F-1 be accelerated so that
it will become effective at 9:00 a.m. Eastern time on September 27, 2024, or as soon as practicable thereafter.
Please contact our outside counsel, Meitar Law Offices (Mike Rimon, Adv. at +972-3-6145822 or mrimon@meitar.com, Jonathan M. Nathan, Adv. at +972-3-610-3157 or jonathann@meitar.com, or
Elad Ziv, Adv. at+972-3-6142613 or eladz@meitar.com) with any questions, and please notify them when this request for acceleration has been granted.
Sincerely,
EVOGENE LTD.
By:
/s/ Ofer Haviv
Name: Ofer Haviv
Title: President and Chief Executive Officer
cc:
Meitar Law Offices
Mike Rimon, Adv.
Jonathan M. Nathan, Adv.
Elad Ziv, Adv.